Consolidation and maintenance rituximab therapy in chronic lymphocytic leukemia

Saved in:
Bibliographic Details
Published inCurrent oncology reports Vol. 10; no. 5; pp. 363 - 364
Main Authors Lamanna, Nicole, Weiss, Mark A.
Format Journal Article
LanguageEnglish
Published New York Current Science Inc 01.09.2008
Subjects
Aged
Antibodies, Monoclonal - administration & dosage
Antibodies, Monoclonal - therapeutic use
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents - therapeutic use
Clinical Trials Report
Disease-Free Survival
Flow Cytometry - methods
Humans
Immunotherapy - methods
Leukemia, Lymphocytic, Chronic, B-Cell - therapy
Medicine
Medicine & Public Health
Middle Aged
Oncology
Remission Induction
Rituximab
Treatment Outcome
Vidarabine - administration & dosage
Vidarabine - analogs & derivatives
Chronic Lymphocytic Leukemia Patient
Minimal Residual Disease
Response Duration
Pentostatin
Clin Oncol
Online AccessGet full text

Cover

More Information
ISSN:1523-3790
1534-6269
DOI:10.1007/s11912-008-0056-1